translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
en
Identifícate
Portal da
INVESTIGACIÓN
Grupos
Investigadores/as
Resultados
Manuel Francisco
Otero Santiago
Manuel
Campos Toimil
Estás en
Colaboracións
Manuel Campos Toimil
Publicacións nas que colabora con Manuel Campos Toimil (2)
2023
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161
2022
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Frontiers in Pharmacology, Vol. 13